Ве молиме користете го овој идентификатор да го цитирате или поврзете овој запис: http://hdl.handle.net/20.500.12188/11553
DC FieldValueLanguage
dc.contributor.authorOhyashiki, Ken_US
dc.contributor.authorKocova, Men_US
dc.contributor.authorRyan, D Hen_US
dc.contributor.authorRowe, J Men_US
dc.contributor.authorSandberg, A Aen_US
dc.date.accessioned2021-03-25T11:03:59Z-
dc.date.available2021-03-25T11:03:59Z-
dc.date.issued1986-01-15-
dc.identifier.issn0165-4608-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/11553-
dc.description.abstractPh-positive acute myeloblastic leukemia (AML) developing in a treated case of Wegener's granulomatosis is reported. The patient was a 70-year-old white male who received cyclophosphamide (150 mg/day) starting in July 1978; in May 1984 the patient was diagnosed as having AML, following a diagnosis of myelodysplastic syndrome lasting 3 months. Cytogenetic study of bone marrow cells at the diagnosis of the myelodysplastic syndrome revealed a standard Ph translocation in addition to numerical chromosome changes [i.e., 45,XY, -5, -7, -8, +19, +mar/45,XY, -5, -7, -8, +19, +mar,t(9;22)(q34;q11]). The events in this case suggest a strong possibility of the Ph-positive AML being a secondary disease related to prior cyclophosphamide therapy.en_US
dc.language.isoenen_US
dc.publisherELSEVIER SCIENCE INCen_US
dc.relation.ispartofCancer genetics and cytogeneticsen_US
dc.titleSecondary acute myeloblastic leukemia with a Ph translocation in a treated Wegener's granulomatosisen_US
dc.typeArticleen_US
dc.identifier.doi10.1016/0165-4608(86)90062-2-
dc.identifier.volume19-
dc.identifier.issue3-4-
item.fulltextNo Fulltext-
item.grantfulltextnone-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Journal Articles
Прикажи едноставен запис

Page view(s)

111
Last Week
0
Last month
checked on 27.7.2025

Google ScholarTM

Проверете

Altmetric


Записите во DSpace се заштитени со авторски права, со сите права задржани, освен ако не е поинаку наведено.